Salt Restriction Affects the Excretions of Minerals (Na, K, Ca, Mg, P and Zn) in the Second Voided Fasting Early Morning Urine.

The plasma concentrations of mineral (sodium (Na), potassium (K), calcium (Ca), magnesium (Mg), phosphorus (P), and zinc (Zn)) are kept within narrow ranges to maintain homeostasis; hence, it is difficult to use them as indicators of nutritional status. We selected the excretion of these minerals in the second voided fasting early morning urine (EMU) as potential indicators of nutritional status. We previously reported that Na restriction caused a negative balance of Ca and Mg. Therefore, Na restriction can cause changes in EMU-minerals. This study aimed to examine the relationship between dietary Na restriction and urinary mineral excretion. The study lasted for 21 d, including 16 d of balance period and 3 d of recovery period. The participants (11 healthy young women) were divided into the Na restriction group (n=5) (NaCl: 6 g/d) and control group (n=6) (NaCl: 12 g/d). The Na restriction group changed to the control diet (NaCl: 12 g/d) during only the recovery period. The EMU-Na, Ca, Mg, P and Zn in the Na restriction group significantly decreased compared with that of the control group. The EMU-Na, K, Ca, Mg, and Zn in the group with NaCl intake of 6 g/d significantly decreased compared with that of the group with NaCl intake of 12 g/d (in the Na restriction group). We conclude that the decrease in excretion of Na, Ca, Mg and Zn in the EMU can lead to Na restriction. This result can serve as basis when considering EMU as an indicator of mineral status.

Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial.

OBJECTIVE: Equol is a metabolite of the isoflavone daidzein and may play a critical role in preventing bone loss by soy isoflavones in postmenopausal women. However, results from clinical trials have not been published. The aim of this study was to investigate the effects of equol on bone metabolism and serum sex and thyroid hormone levels in postmenopausal Japanese women. METHODS: We performed a 1-year double-blind, randomized, placebo-controlled trial with natural S-equol supplements for 93 non-equol-producing menopausal Japanese women. Participants were randomly assigned to four groups receiving the following: placebo, 2 mg of equol supplement per day, 6 mg of equol supplement per day, and 10 mg of equol supplement per day. RESULTS: Equol intervention increased equol concentrations in serum and urine in a dose-dependent manner. Urinary deoxypyridinoline was significantly decreased, with a -23.94% change in the group that received 10 mg of equol supplement per day as compared with a -2.87% change in the group that received placebo after 12 months of intervention (P = 0.020). Thus, 10 mg/day of equol supplement markedly inhibited bone resorption. Treatment with 10 mg/day of equol prevented a decrease in bone mineral density in the entire body in postmenopausal women after 12 months. Sex and thyroid hormone concentrations in serum did not differ among the four groups after intervention. CONCLUSIONS: These findings suggest that 10 mg/day of natural S-equol supplementation contributes to bone health in non-equol-producing postmenopausal women without adverse effects.

Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women.

It has been reported that treatment with a pharmacological dose (45 mg/d) of menaquinone-4 (MK-4) prevents bone loss in postmenopausal women. However, it is not known whether supplementation with low dose MK-4 has beneficial effects on bone metabolism in healthy women. The aim of this study is to examine the effects of the supplementation of 1.5 mg/d MK-4 for 4 wk on bone and lipid metabolism in healthy postmenopausal Japanese women. The study was performed as a randomized double blind placebo-controlled trial. The participants aged 53-65 y were randomly assigned to 2 groups and supplemented with 1.5 mg/d of MK-4 or a placebo for 4 wk (n=20 for each group). The most marked effects of MK-4 intake were observed on serum osteocalcin (OC) concentrations. Serum undercarboxylated OC (ucOC) concentration decreased, and the gamma-carboxylated OC (GlaOC) and GlaOC/GlaOC+ucOC ratio that indicates the degree of OC gamma-carboxylation increased significantly at 2 and 4 wk compared with that at baseline in the MK-4 group. The serum ucOC and GlaOC concentrations in the MK-4 group were significantly different from those in the placebo group at 2 wk. These results suggest that supplementation with 1.5 mg/d MK-4 accelerated the degree of OC gamma-carboxylation. The concentrations of serum lipids and other indices were not different between the groups at either intervention period. Thus, the additional intake of MK-4 might be beneficial in the maintenance of bone health in postmenopausal Japanese women.

Balances of calcium, magnesium and phosphorus in Japanese young adults.

This study was conducted to estimate the requirements of calcium (Ca), magnesium (Mg) and phosphorus (P) in Japanese young adults. From 1986 to 2000, 109 volunteers 123 males, 86 females), ranging from 18 to 28 y old, took part in mineral balance studies after written informed consent was obtained. The duration of the study periods ranged from 5 to 12 d, with 2-4 d of adaptation. Foodstuffs used in each study were selected from those commercially available. The minerals present in diet, feces, urine and sweat were measured by atomic absorption spectrophotometer (Ca, Mg) or spectrophotometer (P). The dietary intakes of Ca, Mg and P ranged from 4.83-23.58, 2.44-7.83 and 13.46-45.69 mg/ kg BW/d, respectively. Dietary intake (Intake) of Ca was positively correlated to apparent absorption (A.A.) (r2 = 0.425), which was also correlated with urine excretion (Urine) (r2 = 0.327) and balance (Bal) (r2 = 0.382). Intake of Ca was slightly but significantly correlated with Bal (r2 = 0.036, p = 0.048). The mean value and upper limit of the 95% confidence interval for the regression equation between Intake and Bal when balance is equal to zero (Mean and upper limit) for Ca were 11.752 and 12.555 mg/kg BW/d, respectively. Intake of Mg was positively correlated to A.A. (r2 = 0.451), which was also correlated with Urine (r2 = 0.486) and Bal (r2 = 0.349). However, Intake of Mg was not correlated with Bal. Intake of P was positively correlated with A.A. (r2 = (0.959), which was also correlated with both Urine (r2 = 0.908) and Bal (r2 = 0.135). Intake of P was slightly but significantly correlated with Bal (r2 = 0.103, p = 0.0013). Mean and upper limits for P were 22.584 and 24.059 mg/kg BW/d, respectively. Intakes of Mg and P correlated negatively with their respective A.A. rates (%) (r2 = 0.120 for Mg, r2 = 0.109 for P). However, there was not much of a correlation for Ca. Balance of Ca was positively correlated with that of Mg (r2 = 0.541), but not with that of P.

Balance of magnesium positively correlates with that of calcium.

BACKGROUND AND OBJECTIVE: In a prior study, we showed no significant relationship between intake and balance of magnesium (Mg). Subsequent further investigation disclosed that intakes of both Ca and P were positively correlated with their respective balances, whereas intake of Mg did not show any significant correlation with Mg balance. In this paper, we show positive correlations between intake of Mg and balances of both Ca and P. METHODS AND RESULTS: Using these correlations, the mean value and upper limit of the 95% confidence interval (from the regression equation between Mg intake and either the balances of Ca or that of P, when each balance is equal to zero) were 4.584 and 4.802 (against Ca balance), 4.554 and 4.785 (against P balance) mg/kg BW/d, respectively. Balances of Mg and Ca correlated with each other.